The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Research Funding - Bristol-Myers Squibb (Inst); Kyowa Kirin (Inst); Ono Pharmaceutical (Inst)
Real-world efficacy of chemotherapy in patients with advanced extramammary Paget's disease: A retrospective, multicenter study of 204 Japanese patients.
 
Azusa Miyashita
No Relationships to Disclose
 
Satoshi Fukushima
Speakers' Bureau - Sanofi; Taiho Pharmaceutical
Research Funding - Kyowa Kirin Co.,Ltd.; Nippon Kayaku; Sanofi; Taiho Pharmaceutical
 
Koji Yoshino
No Relationships to Disclose
 
Hiroshi Kato
Research Funding - Taiho Pharmaceutical (Inst)
 
Naoya Yamazaki
Consulting or Advisory Role - Incyte; Maruho; Ono Pharmaceutical; Otsuka
Speakers' Bureau - Bristol-Myers Squibb Japan; Maruho; MSD; Novartis; Ono Pharmaceutical; Sun Pharma
Research Funding - Astellas Amgen BioPharama (Inst); Bristol-Myers Squibb Japan (Inst); GlaxoSmithKline; Merck Serono (Inst); Novartis (Inst); Ono Pharmaceutical (Inst); Takara Bio (Inst)
 
Shusuke Kawashima
No Relationships to Disclose
 
Yuki Yamamoto
No Relationships to Disclose
 
Yasuhiro Nakamura
Honoraria - Bristol-Myers Squibb Japan; Kyowa Kirin International; Maruho; Mitsubishi Tanabe Pharma; MSD Oncology; Novartis Pharmaceuticals UK Ltd.; Ono Pharmaceutical; Sun Pharma
Consulting or Advisory Role - Novartis Pharmaceuticals UK Ltd.
Research Funding - Torii Pharmaceutical (Inst)
 
Yukiko Kiniwa
No Relationships to Disclose
 
Shoichiro Ishizuki
No Relationships to Disclose
 
Takeo Maekawa
Speakers' Bureau - Taiho Pharmaceutical
Research Funding - Kyowa Kirin (Inst); Sanofi (Inst); Taiho Pharmaceutical (Inst)
 
Etsuko Okada
Research Funding - Taiho Pharmaceutical (Inst)
 
Taku Fujimura
Research Funding - Kyowa Kirin (Inst); Nippon Kayaku (Inst); Sanofi (Inst); Taiho Pharmaceutical (Inst)
 
Kazuyasu Fujii
No Relationships to Disclose
 
Yasuhiro Fujisawa
Consulting or Advisory Role - MSD; Novartis
Speakers' Bureau - Bristol-Myers Squibb; MSD; Novartis; Ono Pharmaceutical
Research Funding - Ono Pharmaceutical (Inst)
 
Jun Asai
No Relationships to Disclose
 
Atsushi Otsuka
Speakers' Bureau - Sanofi; Taiho Pharmaceutical
Research Funding - Sanofi (Inst); Taiho Pharmaceutical (Inst)
 
Jun Morinaga
No Relationships to Disclose
 
Shigeto Matsushita
No Relationships to Disclose